Has David Champion, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,734 in general payments to David Champion, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Champion, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Champion, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Champion, MD

Family Medicine · Brownsville, TXNPI 1326046004

Payments from drug & device makers

$11,734in general payments, 2019–2025

Across 32 payments — averaging $366.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

CSL Plasma Inc.$11K
Alkermes, Inc.$97
Otsuka America Pharmaceutical, Inc.$91
Teva Pharmaceuticals USA, Inc.$67
Neurocrine Biosciences, Inc.$51
Vanda Pharmaceuticals Inc.$26
plus $123 from 7 others

What the payments were for

Consulting fees$11,28096%
Food & beverage$4544%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
CSL Plasma Inc.	8	$11,280
Alkermes, Inc.	5	$97
Otsuka America Pharmaceutical, Inc.	4	$91
Teva Pharmaceuticals USA, Inc.	4	$67
Neurocrine Biosciences, Inc.	2	$51
Vanda Pharmaceuticals Inc.	1	$26
Takeda Pharmaceuticals U.S.A., Inc.	2	$25
Argon Medical Devices, Inc.	1	$19
Johnson & Johnson	1	$17
Shire North American Group Inc	1	$17
Corium, LLC	1	$16
Ironshore Pharmaceuticals Inc.	1	$16
Indivior Inc.	1	$13

How this compares

$11,734 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas →

Medicare billing

Part B allowed, 2024

$8,205

Medicare patients

Services billed

133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	43	$45,880
FarxigaDapagliflozin Propanediol	32	$32,337
JanuviaSitagliptin Phosphate	29	$28,050
TrulicityDulaglutide	13	$14,090
Metformin Hcl	99	$1,304
Atorvastatin Calcium	82	$1,017
FenofibrateFenofibrate Nanocrystallized	20	$896
Rosuvastatin Calcium	52	$831
Glipizide	36	$786
Tolterodine Tartrate ErTolterodine Tartrate	14	$700
Lisinopril	63	$543
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide	33	$526
Glipizide ErGlipizide	21	$512
Losartan Potassium	26	$494
Pioglitazone Hcl	16	$451

Paid to pharmacies, not to this prescriber.

Other family medicine in Brownsville

Douglas DenhamSan Antonio$68.5M
Vicki MillerPasadena$58.3M
Hareshkumar BogharaDesoto$30.3M
Earl MartinTomball$30.1M
Lisa HollowayHouston$30.1M
William SegerFort Worth$27.5M
Veronica FragosoHouston$24.5M
Joel SolisMcAllen$21.1M
George AtieeSan Antonio$19.9M
Bonnie ColvilleHouston$19.6M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →